BPC-157

BPC-157

Key Research area 

BPC-157 has been investigated in preclinical models involving:

● Cellular and tissue-repair mechanisms

● Angiogenesis-associated pathways

● Inflammatory-response signaling

● Gastrointestinal tissue biology

● Fibroblast activity and cellular migration

● Collagen-associated processes

● Vascular signaling

● Nervous-system and neurobiological research

Research Status

Research involving BPC-157 remains largely preclinical, and findings from laboratory or animal studies should not be interpreted as establishing safety, efficacy, or therapeutic benefit in humans.

BPC-157 is not approved by the U.S. Food and Drug Administration (FDA) for human therapeutic use.

For Research Use Only. Not for human or veterinary use or consumption. Reign does not provide medical advice, dosing guidance, injection protocols, administration instructions, or recommendations for human use. This product is not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition.